KINGSTON, Jamaica — Medicanja Limited is preparing to undertake commercial production and get to market by the end of August Epilec-Pro, a new medication produced from ganja that has been proven to treat persons diagnosed with epilepsy, the Sunday Gleaner reported on July 15.
“The Ministry of Health approved us in December 2017 based on the work done through Biotech R and D Institute based at the University of the West Indies, Mona campus. We are ready for market, ready to license it or to go into any other country to manufacture it. We are ready,” an excited Dr Henry Lowe, executive chairman of the Jamaican firm Medicanja, told The Sunday Gleaner.
He said the approval from the health ministry was based on the results of clinical studies which showed Epilec-Pro is successful in treating patients who suffer from different types of seizures including absence, tonic-clonic, atonic, tonic and myoclonic, which are categorised as generalised seizures, and focal or partial seizures. http://jamaica-gleaner.com/article/news/20180715/medical-marijuana-boom-ganja-based-medication-treat-epilepsy-could-hit-market
